Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dendritic Cells | 6 | 2023 | 2748 | 0.770 |
Why?
|
Histiocytes | 2 | 2022 | 97 | 0.770 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2024 | 3626 | 0.650 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2017 | 30 | 0.650 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2022 | 1437 | 0.610 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1104 | 0.600 |
Why?
|
Tumor Escape | 1 | 2021 | 372 | 0.590 |
Why?
|
Antigens | 1 | 2022 | 1444 | 0.540 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 701 | 0.530 |
Why?
|
Interferons | 3 | 2023 | 720 | 0.520 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.520 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 308 | 0.490 |
Why?
|
Autoimmune Diseases | 2 | 2020 | 2260 | 0.480 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.470 |
Why?
|
Gene Silencing | 1 | 2021 | 1505 | 0.470 |
Why?
|
Immunity, Innate | 3 | 2024 | 3080 | 0.470 |
Why?
|
Histones | 2 | 2024 | 2603 | 0.460 |
Why?
|
Immunologic Memory | 1 | 2020 | 1378 | 0.440 |
Why?
|
Inflammation | 9 | 2024 | 10869 | 0.440 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2848 | 0.430 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 710 | 0.400 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 515 | 0.380 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 348 | 0.370 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 616 | 0.360 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 395 | 0.330 |
Why?
|
Skin | 1 | 2023 | 4507 | 0.330 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10276 | 0.310 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5864 | 0.310 |
Why?
|
Hematologic Neoplasms | 4 | 2023 | 1907 | 0.310 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2013 | 977 | 0.290 |
Why?
|
NF-kappa B | 1 | 2015 | 2492 | 0.280 |
Why?
|
Dioxygenases | 3 | 2024 | 352 | 0.260 |
Why?
|
Interleukin-17 | 1 | 2012 | 925 | 0.260 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 403 | 0.260 |
Why?
|
Cytokines | 1 | 2020 | 7453 | 0.250 |
Why?
|
Melanoma, Experimental | 2 | 2019 | 559 | 0.250 |
Why?
|
Myocarditis | 1 | 2013 | 803 | 0.250 |
Why?
|
Antiviral Agents | 1 | 2018 | 3069 | 0.250 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4919 | 0.240 |
Why?
|
Interferon-gamma | 1 | 2013 | 3163 | 0.240 |
Why?
|
Nitric Oxide | 1 | 2013 | 2149 | 0.230 |
Why?
|
Immune Tolerance | 1 | 2013 | 2323 | 0.220 |
Why?
|
Mutation | 12 | 2024 | 30266 | 0.220 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 97 | 0.220 |
Why?
|
Thiadiazoles | 1 | 2023 | 63 | 0.220 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 50 | 0.220 |
Why?
|
Myeloid Progenitor Cells | 1 | 2023 | 112 | 0.220 |
Why?
|
Naphthalenes | 1 | 2023 | 198 | 0.210 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4356 | 0.190 |
Why?
|
Histone Demethylases | 1 | 2024 | 328 | 0.190 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 560 | 0.190 |
Why?
|
Endothelial Cells | 3 | 2014 | 3591 | 0.180 |
Why?
|
Hepatitis | 1 | 2023 | 228 | 0.180 |
Why?
|
Cell Movement | 2 | 2014 | 5216 | 0.180 |
Why?
|
Nissl Bodies | 1 | 2020 | 16 | 0.180 |
Why?
|
Interleukin-1beta | 2 | 2024 | 1027 | 0.180 |
Why?
|
Signal Transduction | 6 | 2024 | 23652 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 1408 | 0.170 |
Why?
|
Atherosclerosis | 2 | 2014 | 3431 | 0.170 |
Why?
|
Clone Cells | 1 | 2023 | 1670 | 0.170 |
Why?
|
Macrophages | 3 | 2019 | 5800 | 0.160 |
Why?
|
Menopause, Premature | 1 | 2020 | 124 | 0.160 |
Why?
|
Animals | 21 | 2024 | 169408 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 359 | 0.160 |
Why?
|
Humans | 48 | 2024 | 768887 | 0.160 |
Why?
|
Myeloid Cells | 1 | 2023 | 840 | 0.160 |
Why?
|
Penicillin G Benzathine | 1 | 2018 | 25 | 0.160 |
Why?
|
Histiocytic Sarcoma | 1 | 2019 | 40 | 0.160 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2018 | 32 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2017 | 1602 | 0.150 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 250 | 0.150 |
Why?
|
Organ Specificity | 1 | 2023 | 1970 | 0.150 |
Why?
|
Receptors, Interleukin-6 | 1 | 2019 | 224 | 0.150 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2414 | 0.150 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 209 | 0.150 |
Why?
|
Mice | 16 | 2023 | 82074 | 0.150 |
Why?
|
Cell Death | 1 | 2023 | 1682 | 0.150 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2019 | 125 | 0.140 |
Why?
|
Enteric Nervous System | 1 | 2020 | 213 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1363 | 0.140 |
Why?
|
DNA Transposable Elements | 1 | 2021 | 764 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 996 | 0.140 |
Why?
|
Loss of Heterozygosity | 2 | 2017 | 663 | 0.140 |
Why?
|
Single-Cell Analysis | 4 | 2022 | 2542 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2019 | 5905 | 0.130 |
Why?
|
Adenosine Deaminase | 1 | 2018 | 253 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 871 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2016 | 190 | 0.130 |
Why?
|
Disease Susceptibility | 1 | 2023 | 1794 | 0.130 |
Why?
|
Bacillus cereus | 1 | 2015 | 36 | 0.130 |
Why?
|
Neoplasms | 2 | 2023 | 22390 | 0.130 |
Why?
|
Syphilis | 1 | 2018 | 243 | 0.130 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3951 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 3 | 2023 | 3408 | 0.120 |
Why?
|
Gout | 1 | 2022 | 621 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2017 | 438 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 812 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 82 | 0.120 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 384 | 0.120 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.120 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15662 | 0.110 |
Why?
|
Cell Lineage | 1 | 2023 | 2576 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2021 | 1803 | 0.110 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.110 |
Why?
|
ras Proteins | 1 | 2019 | 1058 | 0.110 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 254 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2126 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.100 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 342 | 0.100 |
Why?
|
Hematopoiesis | 4 | 2023 | 2059 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1064 | 0.100 |
Why?
|
Endothelium, Vascular | 3 | 2014 | 4428 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1962 | 0.100 |
Why?
|
Cell-Derived Microparticles | 1 | 2014 | 161 | 0.100 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9549 | 0.100 |
Why?
|
Leukocyte Rolling | 1 | 2012 | 69 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2022 | 3671 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1606 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1384 | 0.100 |
Why?
|
Genetic Engineering | 1 | 2017 | 936 | 0.100 |
Why?
|
Virus Diseases | 1 | 2018 | 724 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6569 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1494 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2519 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1880 | 0.090 |
Why?
|
Female | 25 | 2024 | 397464 | 0.090 |
Why?
|
Chromatin | 2 | 2021 | 2981 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 998 | 0.090 |
Why?
|
Lymphoma, B-Cell | 1 | 2017 | 945 | 0.090 |
Why?
|
Transcription Factors | 2 | 2024 | 12174 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 865 | 0.090 |
Why?
|
Virus Replication | 1 | 2018 | 2458 | 0.080 |
Why?
|
Immunotherapy | 2 | 2023 | 4755 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1891 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3233 | 0.080 |
Why?
|
RNA, Viral | 1 | 2018 | 2871 | 0.080 |
Why?
|
Immunophenotyping | 3 | 2019 | 1866 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4651 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3613 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1755 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3811 | 0.080 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2011 | 660 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4095 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 22381 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5342 | 0.070 |
Why?
|
Inflammasomes | 2 | 2023 | 540 | 0.070 |
Why?
|
Chemokines | 1 | 2012 | 963 | 0.070 |
Why?
|
Genomics | 3 | 2019 | 5928 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3608 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1982 | 0.070 |
Why?
|
Male | 22 | 2024 | 365249 | 0.070 |
Why?
|
Aged | 14 | 2024 | 171790 | 0.070 |
Why?
|
Adult | 16 | 2024 | 223818 | 0.070 |
Why?
|
Middle Aged | 16 | 2024 | 223740 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1425 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8664 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 1642 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2020 | 12809 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18366 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3540 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2021 | 14485 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4593 | 0.060 |
Why?
|
Diet | 1 | 2021 | 8090 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2041 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 3116 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2543 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 17174 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1813 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9618 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 174 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9524 | 0.050 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18065 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 406 | 0.040 |
Why?
|
Alendronate | 1 | 2021 | 174 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5803 | 0.040 |
Why?
|
Reed-Sternberg Cells | 1 | 2019 | 78 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7472 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2019 | 98 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1714 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 690 | 0.040 |
Why?
|
Olfactory Bulb | 1 | 2019 | 198 | 0.040 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2019 | 140 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 168 | 0.040 |
Why?
|
Lysosomes | 1 | 2023 | 940 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 558 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2019 | 176 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 313 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 551 | 0.040 |
Why?
|
Osteoclasts | 1 | 2021 | 713 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 910 | 0.040 |
Why?
|
RNA Editing | 1 | 2018 | 150 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2018 | 292 | 0.040 |
Why?
|
Ribosomes | 1 | 2020 | 499 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 354 | 0.030 |
Why?
|
Risk Factors | 5 | 2024 | 74971 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6856 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6401 | 0.030 |
Why?
|
Interleukins | 1 | 2021 | 796 | 0.030 |
Why?
|
Cell Adhesion | 2 | 2014 | 3102 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9213 | 0.030 |
Why?
|
Doxycycline | 1 | 2018 | 349 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3253 | 0.030 |
Why?
|
Contact Tracing | 1 | 2018 | 275 | 0.030 |
Why?
|
Apoptosis | 2 | 2022 | 9528 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 505 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 770 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 504 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3283 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1780 | 0.030 |
Why?
|
Anemia, Myelophthisic | 1 | 2014 | 6 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1337 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2014 | 31 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 960 | 0.030 |
Why?
|
Tumor Lysis Syndrome | 1 | 2014 | 38 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15875 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2211 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13677 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59738 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13699 | 0.030 |
Why?
|
Neck | 1 | 2018 | 736 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2014 | 187 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12873 | 0.030 |
Why?
|
Azepines | 1 | 2014 | 329 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1779 | 0.030 |
Why?
|
Colon | 1 | 2020 | 1804 | 0.030 |
Why?
|
E-Selectin | 1 | 2014 | 578 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4528 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21545 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 692 | 0.020 |
Why?
|
Acetylation | 1 | 2014 | 1056 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54950 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4941 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2009 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2126 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1248 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2081 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2055 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9682 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2014 | 792 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 2986 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2014 | 549 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2858 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 422 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16735 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1665 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10486 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2674 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9621 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1836 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 904 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2727 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2574 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2935 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 30044 | 0.020 |
Why?
|
Mitochondria | 1 | 2022 | 3683 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3701 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3621 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4432 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12430 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9564 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1369 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 60110 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5794 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2011 | 733 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1728 | 0.020 |
Why?
|
Adolescent | 3 | 2019 | 89247 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12563 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11886 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 13048 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1625 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10115 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11684 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4032 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13020 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9344 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8765 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13087 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7609 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5716 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16051 | 0.010 |
Why?
|
Child | 2 | 2019 | 80969 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39394 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19023 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2017 | 81892 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6673 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14795 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41800 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36541 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8055 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42684 | 0.010 |
Why?
|
United States | 1 | 2021 | 73180 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21187 | 0.010 |
Why?
|
HIV Infections | 1 | 2018 | 17589 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20776 | 0.010 |
Why?
|
Brain | 1 | 2018 | 27476 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 65485 | 0.010 |
Why?
|